Chlorpheniramine maleate is an alkylamine antihistamine which is used in the treatment of allergic conditions such as rhinitis and urticaria.
This compound blocks histamine during allergic reactions, thus preventing allergic symptoms namely runny nose, watery eyes, sneezing, and itching.
The global Chlorpheniramine Maleate market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Chlorpheniramine Maleate volume and value at global level, regional level and company level. From a global perspective, this report represents overall Chlorpheniramine Maleate market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Sun Pharmaceutical Industries
Johnson & Johnson
Segment by Regions
Segment by Type
By Dosage form
Segment by Application